USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Earnings Per Share

Earnings Per Share

12 Months Ended

Dec. 31, 2016

NOTE M – EARNINGS PER SHARE

Basic earnings per share are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic earnings per share based on the time they were outstanding in any period. Diluted earnings per common share are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted earnings per share calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.

The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the periods indicated:


	Year Ended
	2014	2015	2016

Net earnings available to common shareholders	$ 76,636	$ 94,672	$ 100,041

Weighted average common shares outstanding - basic	26,443	25,460	24,185

Dilutive effect of in-the-money equity awards	934	895	862

Weighted average common shares outstanding - diluted	27,377	26,355	25,047


Earnings per common share from net earnings - basic	$ 2.90	$ 3.72	$ 4.14

Earnings per common share from net earnings - diluted	$ 2.80	$ 3.59	$ 3.99



Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that
their effect would be anti-dilutive:

	Year Ended
	2014	2015	2016

	574	786	2,242